Abstract |
11beta-Hydroxysteroid dehydrogenase type 2 (11beta-HSD2) plays a crucial role in converting hormonally active cortisol to inactive cortisone, thereby conferring specificity upon the mineralocorticoid receptor (MR). Mutations in the gene encoding 11beta-HSD2 (HSD11B2) account for an inherited form of hypertension, the syndrome of "Apparent Mineralocorticoid Excess" ( AME) where cortisol induces hypertension and hypokalaemia. We report five different mutations in the HSD11B2 gene in four families from Oman with a total of 9 affected children suffering from AME. Sequence data demonstrate the previously described L114Delta6nt mutation in exon 2 and new mutations in exon 3 (A221V), exon 5 (V322ins9nt) and for the first time in exon 1 (R74G and P75Delta1nt) of the HSD11B2 gene. These additional mutations provide further insight into AME and the function of the 11beta-HSD2 enzyme. The prevalence of monogenic forms of hypertension such as AME remains uncertain. However, our data suggests AME may be a relevant cause of hypertension in certain ethnic groups, such as the Oman population.
|
Authors | M Quinkler, B Bappal, N Draper, A J Atterbury, G G Lavery, E A Walker, V DeSilva, N F Taylor, S Hala, N Rajendra, P M Stewart |
Journal | Molecular and cellular endocrinology
(Mol Cell Endocrinol)
Vol. 217
Issue 1-2
Pg. 143-9
(Mar 31 2004)
ISSN: 0303-7207 [Print] Ireland |
PMID | 15134813
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Mineralocorticoids
- 11-beta-Hydroxysteroid Dehydrogenases
- Cortisone
|
Topics |
- 11-beta-Hydroxysteroid Dehydrogenases
(genetics, metabolism)
- Case-Control Studies
- Child, Preschool
- Cortisone
(metabolism)
- Exons
(genetics)
- Female
- Genetic Predisposition to Disease
- Humans
- Hypertension
(congenital, genetics, physiopathology)
- Infant
- Male
- Mineralocorticoids
(metabolism)
- Mutation
- Oman
- Pedigree
- Predictive Value of Tests
|